Literature DB >> 18839151

Impact of regional 5-HT depletion on the cognitive enhancing effects of a typical 5-ht(6) receptor antagonist, Ro 04-6790, in the Novel Object Discrimination task.

M V King1, C H Spicer, A J Sleight, C A Marsden, K C F Fone.   

Abstract

RATIONALE: Selective 5-ht(6) receptor antagonists like Ro 04-6790 prolong memory in many rodent preclinical paradigms, possibly by blocking tonic 5-HT-evoked GABA release and allowing disinhibition of cortico-limbic glutamatergic and cholinergic neurones. If this is the case, behavioural responses to Ro 04-6790 should be abolished by depletion of endogenous 5-HT, and selective lesions of dorsal raphé (DR) or median raphé (MR) 5-HT pathways would allow the neuroanatomical substrates underlying the cognitive effects of 5-ht(6) receptor antagonists to be elucidated.
OBJECTIVES: This study compared the effect of Ro 04-6790 on novel object discrimination (NOD) before and after sham or 5,7-dihydroxytryptamine (5,7-DHT)-induced lesions produced by injection into the lateral ventricles (LV), DR or MR.
MATERIALS AND METHODS: NOD tests used a 4 h inter-trial interval (ITI) and Ro 04-6790 (10 mg kg(-1) i.p.) was administered 20 min before the familiarization trial. Brain region-specific 5-HT depletion was assessed by high performance liquid chromatography with electrochemical detection (HPLC-ED).
RESULTS: Widespread LV or selective MR, but not DR lesions, abolished the ability of Ro 04-6790 to delay natural forgetting. Successful performance of all lesioned rats in subsequent 'drug-free' NOD tests using a 1 h ITI excluded the possibility of any confounding effects on visual acuity or motivation.
CONCLUSIONS: The ability of Ro 04-6790 to prolong object recognition memory requires blockade of MR 5-HT function. Because DR lesions did not produce the expected depletion of striatal 5-HT an additional contribution of DR inputs to this region cannot be completely excluded.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18839151     DOI: 10.1007/s00213-008-1334-1

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  87 in total

1.  5,7-Dihydroxytryptamine: improvement of its selectivity for serotonin neurons in the CNS by pretreatment with desipramine.

Authors:  A Björklund; H G Baumgarten; A Rensch
Journal:  J Neurochem       Date:  1975-04       Impact factor: 5.372

Review 2.  Regulation of GABAergic inhibition by serotonin signaling in prefrontal cortex: molecular mechanisms and functional implications.

Authors:  Zhen Yan
Journal:  Mol Neurobiol       Date:  2002 Oct-Dec       Impact factor: 5.590

3.  Lesion of the median raphe nucleus: a combined behavioral and microdialysis study in rats.

Authors:  H Thomas; H Fink; T R Sohr; M Voits
Journal:  Pharmacol Biochem Behav       Date:  2000-01-01       Impact factor: 3.533

Review 4.  An update on the role of the 5-hydroxytryptamine6 receptor in cognitive function.

Authors:  Kevin C F Fone
Journal:  Neuropharmacology       Date:  2008-07-04       Impact factor: 5.250

Review 5.  Role of serotonin in memory impairment.

Authors:  M C Buhot; S Martin; L Segu
Journal:  Ann Med       Date:  2000-04       Impact factor: 4.709

6.  A new one-trial test for neurobiological studies of memory in rats. 1: Behavioral data.

Authors:  A Ennaceur; J Delacour
Journal:  Behav Brain Res       Date:  1988-11-01       Impact factor: 3.332

7.  5-HT(6) receptor antagonists: lead optimisation and biological evaluation of N-aryl and N-heteroaryl 4-amino-benzene sulfonamides.

Authors:  M Bös; A J Sleight; T Godel; J R Martin; C Riemer; H Stadler
Journal:  Eur J Med Chem       Date:  2001-02       Impact factor: 6.514

Review 8.  A pharmacological analysis of an associative learning task: 5-HT(1) to 5-HT(7) receptor subtypes function on a pavlovian/instrumental autoshaped memory.

Authors:  Alfredo Meneses
Journal:  Learn Mem       Date:  2003 Sep-Oct       Impact factor: 2.460

9.  A novel rat serotonin (5-HT6) receptor: molecular cloning, localization and stimulation of cAMP accumulation.

Authors:  M Ruat; E Traiffort; J M Arrang; J Tardivel-Lacombe; J Diaz; R Leurs; J C Schwartz
Journal:  Biochem Biophys Res Commun       Date:  1993-05-28       Impact factor: 3.575

10.  Induced homotypic collateral sprouting of serotonergic fibers in the hippocampus of rat.

Authors:  F C Zhou; E C Azmitia
Journal:  Brain Res       Date:  1984-08-06       Impact factor: 3.252

View more
  13 in total

1.  Acute concomitant effects of MDMA binge dosing on extracellular 5-HT, locomotion and body temperature and the long-term effect on novel object discrimination in rats.

Authors:  Ratchanee Rodsiri; Clare Spicer; A Richard Green; Charles A Marsden; Kevin C F Fone
Journal:  Psychopharmacology (Berl)       Date:  2010-07-20       Impact factor: 4.530

Review 2.  Spontaneous object recognition and its relevance to schizophrenia: a review of findings from pharmacological, genetic, lesion and developmental rodent models.

Authors:  L Lyon; L M Saksida; T J Bussey
Journal:  Psychopharmacology (Berl)       Date:  2011-11-10       Impact factor: 4.530

Review 3.  Alzheimer's disease and age-related memory decline (preclinical).

Authors:  Alvin V Terry; Patrick M Callahan; Brandon Hall; Scott J Webster
Journal:  Pharmacol Biochem Behav       Date:  2011-02-24       Impact factor: 3.533

4.  Restoration of Physiological Expression of 5-HT6 Receptor into the Primary Cilia of Null Mutant Neurons Lengthens Both Primary Cilia and Dendrites.

Authors:  Atom J Lesiak; Matthew Brodsky; Nathalie Cohenca; Alexandra G Croicu; John F Neumaier
Journal:  Mol Pharmacol       Date:  2018-04-20       Impact factor: 4.436

5.  5-HT6 receptor agonist and antagonist modulates ICV-STZ-induced memory impairment in rats.

Authors:  Anand M Bokare; Mandar Bhonde; Rajan Goel; Yogendra Nayak
Journal:  Psychopharmacology (Berl)       Date:  2018-03-03       Impact factor: 4.530

6.  5-Hydroxytryptamine receptor 6 antagonist, SB258585 exerts neuroprotection in a rat model of Streptozotocin-induced Alzheimer's disease.

Authors:  Nasrin Hashemi-Firouzi; Siamak Shahidi; Sara Soleimani-Asl; Alireza Komaki
Journal:  Metab Brain Dis       Date:  2018-04-17       Impact factor: 3.584

Review 7.  The role of serotonin in the NMDA receptor antagonist models of psychosis and cognitive impairment.

Authors:  Herbert Y Meltzer; Masakuni Horiguchi; Bill W Massey
Journal:  Psychopharmacology (Berl)       Date:  2011-01-08       Impact factor: 4.530

8.  E-6801, a 5-HT6 receptor agonist, improves recognition memory by combined modulation of cholinergic and glutamatergic neurotransmission in the rat.

Authors:  Ian Kendall; Helge A Slotten; Xavier Codony; Javier Burgueño; Peter J Pauwels; Jose M Vela; Kevin C F Fone
Journal:  Psychopharmacology (Berl)       Date:  2010-04-20       Impact factor: 4.530

9.  The mGluR2/3 agonist LY379268 reverses post-weaning social isolation-induced recognition memory deficits in the rat.

Authors:  Caitlin A Jones; Angus M Brown; Dorothee P Auer; Kevin C F Fone
Journal:  Psychopharmacology (Berl)       Date:  2010-07-07       Impact factor: 4.530

10.  Differential effects of cathinone compounds and MDMA on body temperature in the rat, and pharmacological characterization of mephedrone-induced hypothermia.

Authors:  S E Shortall; A R Green; K M Swift; K C F Fone; M V King
Journal:  Br J Pharmacol       Date:  2013-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.